» Articles » PMID: 29380872

Accurate Costs of Blood Transfusion: a Microcosting of Administering Blood Products in the United Kingdom National Health Service

Overview
Journal Transfusion
Specialty Hematology
Date 2018 Jan 31
PMID 29380872
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In an environment of limited health care resources, it is crucial for health care systems which provide blood transfusion to have accurate and comprehensive information on the costs of transfusion, incorporating not only the costs of blood products, but also their administration. Unfortunately, in many countries accurate costs for administering blood are not available. Our study aimed to generate comprehensive estimates of the costs of administering transfusions for the UK National Health Service.

Study Design And Methods: A detailed microcosting study was used to cost two key inputs into transfusion: transfusion laboratory and nursing inputs. For each input, data collection forms were developed to capture staff time, equipment, and consumables associated with each step in the transfusion process. Costing results were combined with costs of blood product wastage to calculate the cost per unit transfused, separately for different blood products. Data were collected in 2014/15 British pounds and converted to US dollars.

Results: A total of 438 data collection forms were completed by 74 staff. The cost of administering blood was $71 (£49) per unit for red blood cells, $84 (£58) for platelets, $55 (£38) for fresh-frozen plasma, and $72 (£49) for cryoprecipitate.

Conclusions: Blood administration costs add substantially to the costs of the blood products themselves. These are frequently incurred costs; applying estimates to the blood components supplied to UK hospitals in 2015, the annual cost of blood administration, excluding blood products, exceeds $175 (£120) million. These results provide more accurate estimates of the total costs of transfusion than those previously available.

Citing Articles

Prognostic models for prediction of perioperative allogeneic red blood cell transfusion in adult cardiac surgery: A systematic review and meta-analysis.

Van den Eynde R, Vrancken A, Foubert R, Tuand K, Vandendriessche T, Schrijvers A Transfusion. 2024; 65(2):397-409.

PMID: 39726297 PMC: 11826302. DOI: 10.1111/trf.18108.


Cost Reduction in Blood Transfusions After Implementation of Decision Protocol Based on Hemoglobin and Anemia Symptoms: A Pre-Post Analysis.

Czempik P, Herzyk J, Wilczek D, Rogalska A Med Sci Monit. 2024; 30:e945854.

PMID: 39628043 PMC: 11626835. DOI: 10.12659/MSM.945854.


The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT.

Jansen J, Hudson J, Kennedy C, Cochran C, MacLennan G, Gillies K Health Technol Assess. 2024; 28(54):1-122.

PMID: 39259521 PMC: 11418015. DOI: 10.3310/LTYV4082.


Myoglobin saturation as an intracellular indicator for transfusion need in oncology patients.

Schenkman K, Ciesielski W, Gernsheimer T, Arakaki L Transfus Med. 2024; 35(1):68-74.

PMID: 39191463 PMC: 11835544. DOI: 10.1111/tme.13090.


Financial challenges faced in blood banks.

Sajwani F Asian J Transfus Sci. 2024; 18(1):157-158.

PMID: 39036685 PMC: 11259354. DOI: 10.4103/ajts.ajts_100_21.